Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Brazil debates legislating on spending levels to support "healthcare pact":

This article was originally published in Clinica

Executive Summary

Brazil's health minister, Jose Gomes Temporao, is pushing for Congress to adopt the so-called "29th constitutional amendment" that would set minimum levels of spending on healthcare, as a proportion of GDP. In an interview for the Gazeta Mercantil (May 21), posted on the health ministry website, he is calling for it to be approved as a matter of urgency, in support of the package of structural, delivery and financing reforms that are known comprehensively as the Pacto pela saude. This "healthcare pact" is important for the way the federal health budget - R$49.74bn (US$25.4bn) in 2007 - is calculated and disbursed across five funding blocks (basic- and medium-technology levels of care; high-complexity inpatient/outpatient procedures; surveillance; copayments; and operational management), instead of across 130 segments of the service.

You may also be interested in...

Hikma Adds Sesen’s Vicineum To MENA Brands

Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.

Netherlands’ Norgine Sets Up OTC Business And Targets Acquisitions

By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.

AAM Urges Supreme Court To Uphold Inter Partes Review

The AAM has insisted that the US Supreme Court should uphold the inter partes review framework, in an amicus brief filed as part of litigation that potentially threatens hundreds of IPR decisions.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts